1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Joly's LLC recalled 80% Vinegar on February 19, 2026, due to serious risks of poisoning and chemical burns. The product lacks essential warning labels and first aid instructions, violating federal safety laws. Consumers should stop using the product immediately and seek a refund.
Vive Health recalled adult portable bed rails on February 19, 2026, due to serious entrapment risks. The recall affects models LVA1024 and LVA3031BLK. Consumers must stop using the product immediately and contact Vive Health for a full refund.
Watkins Manufacturing recalled Hydromassage rotary jets from Highlife Collection spas on February 12, 2026. The jets pose entanglement and drowning hazards to users. Consumers should stop using the jets immediately and check their spas for the recalled parts.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
GM Gumili recalled its Wintergreen Essential Oil on February 6, 2026, after it was found to lack child-resistant packaging. The essential oil contains methyl salicylate, which poses a risk of poisoning to young children if ingested. Consumers should stop using the product immediately and return it for a full refund.
Organic Zing Birch Essential Oil bottles were recalled on February 5, 2026, due to poison risks for children. The essential oil contains methyl salicylate, which requires child-resistant packaging. The recall affects an undisclosed number of bottles sold online by Linkers.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.
Bazic Products recalled Bazic Silicone Glue on January 29, 2026, due to a serious poisoning risk for children. The glue's packaging does not meet child-resistant standards, violating federal law. Consumers should stop using the product immediately and seek a full refund.
Mindbodygreen recalled Ultimate Multivitamin+ dietary supplements on January 29, 2026, due to a risk of child poisoning. The bottles lack child-resistant packaging, violating safety standards. Consumers should stop using the product immediately and secure it out of children's reach.
Nengmiaokeji recalled Sefudun 5% Minoxidil Hair Growth Serum Kit on January 29, 2026. The product lacks child-resistant packaging, posing a serious poisoning risk to children. Consumers should stop using the serum immediately and contact the company for a replacement.
Viofairy recalled its Hair Growth Serum on January 29, 2026, due to serious poisoning risks. The packaging lacks required child-resistant features, endangering young children. Consumers must stop using the product immediately and secure it out of reach.
Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.
Asteria Health recalled 1,464 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects products distributed nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Granules Pharmaceuticals Inc. recalled 71,424 bottles of Trazodone Hydrochloride on January 26, 2026. The recall stems from the presence of foreign tablets or capsules in the product. Consumers should stop using the medication immediately and consult their healthcare provider.
Philips Medical Systems recalled 326 Azurion 5 M12 systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a risk to patients and healthcare providers. Immediate cessation of use is advised.
Philips Medical Systems recalled 1,503 Azurion 7 B20 systems on January 26, 2026. The devices may move unexpectedly when the Reset Geometry button is pressed, posing a risk of injury. Healthcare providers must stop using the device and follow recall instructions immediately.
Philips Medical Systems Nederland B.V. recalled 922 Azurion 5 M20 systems on January 26, 2026, due to a defect that causes unexpected table movement. This hazard can occur even with an active table lock when the Reset Geometry button is pressed. The recall includes 101 units in the U.S. and 821 units distributed worldwide.
Philips Medical Systems recalled 291 Azurion 3 M12 systems on January 26, 2026, due to a risk of unexpected table movement. This may occur when the Reset Geometry button is pressed, even if a table lock is active. The recall affects 27 units in the U.S. and 264 units internationally.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.